
Nathan M. Nutter
Examiner (ID: 6842, Phone: (571)272-1076 , Office: P/1765 )
| Most Active Art Unit | 1711 |
| Art Unit(s) | 1207, 1711, 1503, 1796, 1803, 2899, 1765, 1801 |
| Total Applications | 4828 |
| Issued Applications | 3926 |
| Pending Applications | 193 |
| Abandoned Applications | 716 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3511973
[patent_doc_number] => 05576018
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-11-19
[patent_title] => 'Method for treating neurological disorders'
[patent_app_type] => 1
[patent_app_number] => 8/484501
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6869
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/576/05576018.pdf
[firstpage_image] =>[orig_patent_app_number] => 484501
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/484501 | Method for treating neurological disorders | Jun 6, 1995 | Issued |
Array
(
[id] => 3624500
[patent_doc_number] => 05607968
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-04
[patent_title] => 'Topical alkyl-2-O-L-ascorbyl-phosphates'
[patent_app_type] => 1
[patent_app_number] => 8/487957
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2760
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/607/05607968.pdf
[firstpage_image] =>[orig_patent_app_number] => 487957
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/487957 | Topical alkyl-2-O-L-ascorbyl-phosphates | Jun 6, 1995 | Issued |
Array
(
[id] => 4026193
[patent_doc_number] => 05883124
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-16
[patent_title] => 'Compositions and methods for treating and preventing pathologies including cancer'
[patent_app_type] => 1
[patent_app_number] => 8/484615
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 62
[patent_no_of_words] => 70632
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/883/05883124.pdf
[firstpage_image] =>[orig_patent_app_number] => 484615
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/484615 | Compositions and methods for treating and preventing pathologies including cancer | Jun 6, 1995 | Issued |
Array
(
[id] => 3590436
[patent_doc_number] => 05496840
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-03-05
[patent_title] => 'Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment'
[patent_app_type] => 1
[patent_app_number] => 8/476558
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3634
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/496/05496840.pdf
[firstpage_image] =>[orig_patent_app_number] => 476558
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/476558 | Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment | Jun 6, 1995 | Issued |
Array
(
[id] => 3588323
[patent_doc_number] => 05550144
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-27
[patent_title] => 'Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment'
[patent_app_type] => 1
[patent_app_number] => 8/477550
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3651
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/550/05550144.pdf
[firstpage_image] =>[orig_patent_app_number] => 477550
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/477550 | Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment | Jun 6, 1995 | Issued |
Array
(
[id] => 3547873
[patent_doc_number] => 05545649
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-13
[patent_title] => 'Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment'
[patent_app_type] => 1
[patent_app_number] => 8/474913
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3659
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/545/05545649.pdf
[firstpage_image] =>[orig_patent_app_number] => 474913
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/474913 | Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment | Jun 6, 1995 | Issued |
Array
(
[id] => 3658642
[patent_doc_number] => 05591715
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-07
[patent_title] => 'Methods and compositions for reducing multidrug resistance'
[patent_app_type] => 1
[patent_app_number] => 8/474994
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12343
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/591/05591715.pdf
[firstpage_image] =>[orig_patent_app_number] => 474994
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/474994 | Methods and compositions for reducing multidrug resistance | Jun 6, 1995 | Issued |
Array
(
[id] => 3663404
[patent_doc_number] => 05656733
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-12
[patent_title] => 'Lignin-containing resinous compositions'
[patent_app_type] => 1
[patent_app_number] => 8/483620
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4595
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/656/05656733.pdf
[firstpage_image] =>[orig_patent_app_number] => 483620
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/483620 | Lignin-containing resinous compositions | Jun 6, 1995 | Issued |
Array
(
[id] => 4010381
[patent_doc_number] => 05889110
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-30
[patent_title] => 'Salts of peptides with carboxy-terminated polyesters'
[patent_app_type] => 1
[patent_app_number] => 8/473303
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24974
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/889/05889110.pdf
[firstpage_image] =>[orig_patent_app_number] => 473303
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/473303 | Salts of peptides with carboxy-terminated polyesters | Jun 6, 1995 | Issued |
Array
(
[id] => 3706745
[patent_doc_number] => 05654312
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-05
[patent_title] => 'Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents'
[patent_app_type] => 1
[patent_app_number] => 8/475426
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7317
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/654/05654312.pdf
[firstpage_image] =>[orig_patent_app_number] => 475426
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/475426 | Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents | Jun 6, 1995 | Issued |
Array
(
[id] => 3659859
[patent_doc_number] => 05667806
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-16
[patent_title] => 'Spray drying method and apparatus'
[patent_app_type] => 1
[patent_app_number] => 8/475882
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 8526
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/667/05667806.pdf
[firstpage_image] =>[orig_patent_app_number] => 475882
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/475882 | Spray drying method and apparatus | Jun 6, 1995 | Issued |
Array
(
[id] => 3983640
[patent_doc_number] => 05861387
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-19
[patent_title] => 'Controlled release systems and low dose androgens'
[patent_app_type] => 1
[patent_app_number] => 8/485762
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 20271
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/861/05861387.pdf
[firstpage_image] =>[orig_patent_app_number] => 485762
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/485762 | Controlled release systems and low dose androgens | Jun 6, 1995 | Issued |
Array
(
[id] => 3493040
[patent_doc_number] => 05536739
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-16
[patent_title] => 'Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment'
[patent_app_type] => 1
[patent_app_number] => 8/476097
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3632
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/536/05536739.pdf
[firstpage_image] =>[orig_patent_app_number] => 476097
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/476097 | Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment | Jun 6, 1995 | Issued |
Array
(
[id] => 3590447
[patent_doc_number] => 05567695
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-10-22
[patent_title] => 'Methods for preventing and treating osteoporosis with low dose non-masculinizing androgenic compounds'
[patent_app_type] => 1
[patent_app_number] => 8/483761
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11156
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/567/05567695.pdf
[firstpage_image] =>[orig_patent_app_number] => 483761
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/483761 | Methods for preventing and treating osteoporosis with low dose non-masculinizing androgenic compounds | Jun 6, 1995 | Issued |
Array
(
[id] => 3762272
[patent_doc_number] => 05843994
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-01
[patent_title] => 'Compositions and methods for treating and preventing pathologies including cancer'
[patent_app_type] => 1
[patent_app_number] => 8/478264
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 63
[patent_no_of_words] => 70612
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/843/05843994.pdf
[firstpage_image] =>[orig_patent_app_number] => 478264
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/478264 | Compositions and methods for treating and preventing pathologies including cancer | Jun 6, 1995 | Issued |
Array
(
[id] => 3730039
[patent_doc_number] => 05703188
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-30
[patent_title] => 'Process for removing bile salts from a patient and compositions therefor'
[patent_app_type] => 1
[patent_app_number] => 8/482969
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12596
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/703/05703188.pdf
[firstpage_image] =>[orig_patent_app_number] => 482969
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/482969 | Process for removing bile salts from a patient and compositions therefor | Jun 6, 1995 | Issued |
Array
(
[id] => 3527109
[patent_doc_number] => 05541207
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-30
[patent_title] => 'Anti-neoplastic anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment'
[patent_app_type] => 1
[patent_app_number] => 8/476563
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3646
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/541/05541207.pdf
[firstpage_image] =>[orig_patent_app_number] => 476563
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/476563 | Anti-neoplastic anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment | Jun 6, 1995 | Issued |
Array
(
[id] => 3590407
[patent_doc_number] => 05496838
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-03-05
[patent_title] => 'Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment'
[patent_app_type] => 1
[patent_app_number] => 8/485830
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3660
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/496/05496838.pdf
[firstpage_image] =>[orig_patent_app_number] => 485830
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/485830 | Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment | Jun 6, 1995 | Issued |
Array
(
[id] => 3554335
[patent_doc_number] => 05519041
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-05-21
[patent_title] => 'Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment'
[patent_app_type] => 1
[patent_app_number] => 8/477551
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3683
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/519/05519041.pdf
[firstpage_image] =>[orig_patent_app_number] => 477551
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/477551 | Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment | Jun 6, 1995 | Issued |
Array
(
[id] => 3623499
[patent_doc_number] => 05688944
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-18
[patent_title] => 'Carbamazepine derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/473810
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4196
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/688/05688944.pdf
[firstpage_image] =>[orig_patent_app_number] => 473810
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/473810 | Carbamazepine derivatives | Jun 6, 1995 | Issued |